CD4 and B-cell chronic lymphocytic leukemia: We extend our in vitro findings to demonstrate that CD4 and CD8 T cells show increased baseline Th17 differentiation in CLL patients with early fulminant autoimmune toxicity compared to those without toxicity, and even compared to those with more delayed toxicity.